News for 'Good Manufacturing Practice'

War Exposes Cracks in US-Israel Alliance

War Exposes Cracks in US-Israel Alliance

Rediff.com20 Mar 2026

Alliances fight wars effectively only when they share an endgame. If Israel acted without US knowledge, then the military alliance is operating without real coordination at the level of strategic targeting. Neither picture is reassuring in a war that is no longer regional in its consequences. Prem Panicker continues his must read daily blog on the Gulf War.

76 pharma firms raided, licences of 18 cancelled for manufacturing spurious drugs

76 pharma firms raided, licences of 18 cancelled for manufacturing spurious drugs

Rediff.com28 Mar 2023

In a major crackdown against the manufacture of substandard drugs, central and state regulators conducted joint inspections at 76 pharma companies and cancelled the licences of 18 of them for producing spurious and adulterated drugs, official sources said on Tuesday.

Iran Rewrites Rules of War

Iran Rewrites Rules of War

Rediff.com17 Mar 2026

Iran is fighting a different war: Older, slower, and in some ways more dangerous. Iran doesn't need to shoot down an F/A-18. It only needs to make the Strait of Hormuz feel dangerous long enough for insurance markets, shipping companies, and oil futures traders to do the rest. Prem Panicker continues his must-read daily blog on the war in the Middle East.

Air, Water Purifiers: GST Council May Weigh 5% Levy

Air, Water Purifiers: GST Council May Weigh 5% Levy

Rediff.com30 Dec 2025

The GST Council at its next meeting may consider a reduction in taxes on air and water purifiers as air quality across the country worsens and access to safe drinking water remains uneven.

Is Pharmaceutical Engg Better Than BPham And PharmD?

Is Pharmaceutical Engg Better Than BPham And PharmD?

Rediff.com11 Nov 2025

rediffGURU Nayagam PP advises young aspirants how to pick the right course and career.

Maha suspends licences of 6 cough syrup manufacturers for rule breach

Maha suspends licences of 6 cough syrup manufacturers for rule breach

Rediff.com4 Mar 2023

Rathod said the Maharashtra government had initiated an inquiry against 84 out of 108 manufacturers of cough syrups in the state.

Listed companies' rent, lease expenses down since pandemic

Listed companies' rent, lease expenses down since pandemic

Rediff.com3 Jan 2026

Companies' rent and lease expenses have seen a significant decline relative to the money they make since the pandemic.

New GDP series to improve informal sector estimates

New GDP series to improve informal sector estimates

Rediff.com1 Jan 2026

India's new national accounts will leverage new data sources and surveys to enhance the measurement of the country's informal economy, and introduce double deflation methods across sectors, replacing the current system that relies on a single deflation mechanism in Gross Domestic Product (GDP) calculations.

Lessons To Learn From The Tatas

Lessons To Learn From The Tatas

Rediff.com30 Jan 2026

Usually, in the western view, corporate success is attributed to efficiency, organisational structure, and scale. R Gopalakrishnan and Harish Bhat argue that philosophy, culture, and the transmission of values are more important for sustaining growth and profitability of an enterprise over a period of time.

Trump slaps 100% tariffs on imported pharma products

Trump slaps 100% tariffs on imported pharma products

Rediff.com26 Sep 2025

United States President Donald Trump on Friday announced that his administration will impose a 100 per cent tariff on branded and patented pharmaceutical products beginning October 1, 2025, unless the manufacturing companies are building production facilities in the US.

Modi 3.0's Plans For Ayushman Bharat

Modi 3.0's Plans For Ayushman Bharat

Rediff.com12 Jun 2024

The Centre is considering a proposal on increasing coverage under the Ayushman Bharat scheme to Rs 10 lakh from the current Rs 5 lakh.

Manufacturing norms violated: USFDA slams Cadila

Manufacturing norms violated: USFDA slams Cadila

Rediff.com7 Jul 2011

The regulator has given the company 15 days to take corrective measures and report back to it.

10 Human-Forward Work Skills You Must Master in 2026

10 Human-Forward Work Skills You Must Master in 2026

Rediff.com7 Jan 2026

Here are ten human-forward skills that will quietly but decisively shape professional growth in 2026.

'The Key Is Talent, Technology, Trust'

'The Key Is Talent, Technology, Trust'

Rediff.com30 Dec 2025

'Our problem is not a budget deficit but a trust deficit. We need to trust our institutions and industries to innovate and lead. That is the way forward for India.'

GST reforms expected to ignite animal spirits in financial sector: DEA secy

GST reforms expected to ignite animal spirits in financial sector: DEA secy

Rediff.com18 Nov 2025

Noting that recent uncertainties created by global tariffs have not impacted the Indian economy severely, Anuradha Thakur, secretary, Department of Economic Affairs, said the central government is hopeful that the recent goods and services tax (GST) rationalisation will ignite the much needed animal spirits in the financial sector.

Sale of defective TV: Flipkart, Thomson found guilty of deficiency in service

Sale of defective TV: Flipkart, Thomson found guilty of deficiency in service

Rediff.com26 Jun 2025

Ruling that Flipkart cannot "escape liability" as "mere intermediary" in an online purchase, a consumer commission here has found the e-commerce platform and television manufacturing company Thomson guilty of deficiency in service after a defective TV was delivered to a customer.

India-China trade: Deficit widens to $99.2 bn

India-China trade: Deficit widens to $99.2 bn

Rediff.com30 Aug 2025

The bilateral trade between India and China has been growing at a healthy rate, but the trade gap remains sharply tilted in Beijing's favour. India has time and again flagged its concern over the ballooning trade deficit and the non-trade barriers faced by Indian goods in the Chinese market.

What is Schedule M and why it's mandatory for all pharma units

What is Schedule M and why it's mandatory for all pharma units

Rediff.com12 Jul 2023

With an eye on improving quality assurance in the wake of increased global scrutiny on Indian pharma products, the Centre on Tuesday said that Schedule M of the Drugs and Cosmetics Act, 1940 will be made compulsory for small and medium scale manufacturers in a phased manner. Union Health Minister Mansukh Mandaviya has asked micro-small and medium enterprises in pharma manufacturing to move towards good manufacturing practices (GMP) through self regulation. "This will help in quality assurance and also reduce compliance burden," Mandaviya.

Late Engineering Changes Stall 80% of Auto Launches

Late Engineering Changes Stall 80% of Auto Launches

Rediff.com16 Sep 2025

'The delay is high in India, and even higher in the case of electric vehicles.'

Maharajah of tariffs coming to table: Trump aide on India

Maharajah of tariffs coming to table: Trump aide on India

Rediff.com16 Sep 2025

Ahead of trade talks between Indian and United States officials in Delhi, White House trade advisor Peter Navarro said India, which has the 'highest tariffs' of any major country, is 'coming to the table'.

Why US-China Face-Off Is Advantage India

Why US-China Face-Off Is Advantage India

Rediff.com29 Oct 2025

Amid US-China trade tensions and economic vulnerabilities, India must seize the 'China +1' opportunity, deepen reforms, secure FTAs, and globalise its firms for long-term growth, suggests Ajay Shah.

Making Robots To Help Humanity

Making Robots To Help Humanity

Rediff.com24 Nov 2025

'Our vision is to innovate as many products as we can and solve as many problems as possible.'

Quality Lapses Shut Down Drug Makers

Quality Lapses Shut Down Drug Makers

Rediff.com28 Jun 2024

Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories.

Nitish Kumar Has The Opportunity Of A Lifetime To Change Bihar

Nitish Kumar Has The Opportunity Of A Lifetime To Change Bihar

Rediff.com18 Nov 2025

If he cannot do it this term by using his bureaucracy and experts from different fields, it will be a tragedy, asserts Ramesh Menon.

Brazilian regulator says Covaxin fails to meet GMP standards

Brazilian regulator says Covaxin fails to meet GMP standards

Rediff.com31 Mar 2021

Reacting to it, the vaccine maker said it is working towards resolving the issues cited during the inspection and the order of 20 million doses from the Brazilian government is still active.

Adulterated Drugs On Decline Amid Crackdown

Adulterated Drugs On Decline Amid Crackdown

Rediff.com10 Oct 2024

Rise in raids on illicit drug manufacturing units, alongside arrests for the production, sale, or distribution of spurious or adulterated drugs.

'We Aren't Security Conscious As A Nation'

'We Aren't Security Conscious As A Nation'

Rediff.com6 Nov 2025

'Government officials use Gmail and ordinary phones without basic security consciousness.' 'Interoperability, especially in joint exercises with countries like the US, worries me.' 'It often means we open our systems to them, but they don't reciprocate.' 'They could have kill switches in their systems and might even be able to affect ours.'

Trump slaps 50% tariffs on Brazil, warns against trial of Bolsonaro

Trump slaps 50% tariffs on Brazil, warns against trial of Bolsonaro

Rediff.com10 Jul 2025

United States President Donald Trump announced a 50 per cent tariff on imports from Brazil, starting August 1, and called the trial of former Brazilian President Jair Bolsonaro a 'witch hunt', adding that the 'trial should not take place'.

Amazon, Flipkart deploy war rooms for Rs 1.2 trillion festival battle

Amazon, Flipkart deploy war rooms for Rs 1.2 trillion festival battle

Rediff.com23 Sep 2025

At the stroke of midnight, live dashboards lit up simultaneously across Amazon India's World Trade Centre headquarters and Flipkart's Outer Ring Road office in Bengaluru. In sprawling "war rooms" at both the companies, executives monitored real-time data streams tracking payment speeds, inventory levels, and delivery logistics as millions of shoppers flooded online platforms.

These sectors will NOT face Trump's reciprocal tariffs: GTRI

These sectors will NOT face Trump's reciprocal tariffs: GTRI

Rediff.com3 Apr 2025

Essential and strategic items such as pharmaceuticals, semiconductors, copper, and energy products like oil, gas, coal and LNG are exempted from the 27 per cent import duty announced by the US on Wednesday, according to think tank GTRI.

BYD's Latest EV Makes a Splash in Mumbai

BYD's Latest EV Makes a Splash in Mumbai

Rediff.com25 Jun 2025

The BYD Sealion 7 offers instant, exhilarating power, effortlessly pinning you to your seat with a 0-100 km/h sprint in just 4.5 seconds -- a performance proudly showcased on its rear badging.

Breaking up bad assets: Can IBBI's part-resolution rewire insolvency rules?

Breaking up bad assets: Can IBBI's part-resolution rewire insolvency rules?

Rediff.com7 Jul 2025

The recent notification by the Insolvency and Bankruptcy Board of India (IBBI) allowing part-resolution of stressed assets of companies under the insolvency process has sent many resolution professionals (RPs) and committees of creditors (CoCs) back to the drawing board to reassess their strategies for resolving corporate insolvencies.

Sun Pharma's Halol facility listed under USFDA import alert

Sun Pharma's Halol facility listed under USFDA import alert

Rediff.com8 Dec 2022

Sun Pharmaceutical Industries Ltd on Thursday said its Halol facility in Gujarat has been listed under import alert by the USFDA with products manufactured at the unit now are subject to refusal of admission in the US market. The development follows an inspection of the facility by the US Food and Drug Administration (USFDA) from April 26 to May 9, 2022. "We now wish to inform you that the company has received a communication from the USFDA stating that the facility has been listed under Import Alert," Sun Pharma said in a regulatory filing.

Revised Schedule M elicits mixed response

Revised Schedule M elicits mixed response

Rediff.com8 Jan 2024

A notification of the revised Schedule M rules by the Ministry of Health and Family Welfare has elicited mixed responses from the pharma sector and industry observers. While the industry has welcomed the revision of rules, several analysts said that implementation and compliance can become a challenge for smaller pharmaceutical companies. The Schedule M of the Drugs and Cosmetics Rules specifies the good manufacturing practices (GMPs), which aim to ensure quality of drugs made in the country.

Checks On Drug-Making Units Begins

Checks On Drug-Making Units Begins

Rediff.com29 Dec 2022

The joint inspections is to ensure the safety, efficacy, and quality of drugs available in the country

EV Sales Surge on Back of Government Push; Hybrids Lag

EV Sales Surge on Back of Government Push; Hybrids Lag

Rediff.com8 Jul 2025

Despite the benefits of hybrid technology, a lack of government backing and few launches have kept the segment from gaining ground.

P&G's New Boss Is Big Into Bollywood Movies

P&G's New Boss Is Big Into Bollywood Movies

Rediff.com30 Jul 2025

Shailesh Jejurikar has 'always made an effort to stay close to his roots.'

The Alaska Fiasco: Lessons For India

The Alaska Fiasco: Lessons For India

Rediff.com16 Aug 2025

The point to note for India is that we must not panic. The United States may be our largest export destination, but high tariffs will not exactly mean gloom and doom. Sure, we can throw some morsels as we continue negotiating, but we must be firm that some red lines cannot be crossed, no matter what, asserts Shreekant Sambrani.

'India Can Convert Tariffs Into Win-Win Situation'

'India Can Convert Tariffs Into Win-Win Situation'

Rediff.com11 Aug 2025

'It's important for India to think about areas where it wants the US to move.' 'We can be far more innovative in what we ask the US.' 'Given that there's a package deal, why not do it?'

India imposes its own 'uniquely burdensome' rules: US

India imposes its own 'uniquely burdensome' rules: US

Rediff.com3 Apr 2025

On India, the chart showed that the country charged 52 per cent tariffs on the US "including currency manipulation and trade barriers," and America will now charge India "discounted reciprocal tariffs" of 26 per cent.